Cargando…
Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review
Scleritis refers to a wide spectrum of ocular conditions ranging from mild to sight-threatening scleral inflammation that may compromise visual function and threaten the anatomical integrity of the ocular globe. Most aggressive forms like necrotizing or posterior scleritis are often difficult-to-tre...
Autores principales: | Sota, Jurgen, Girolamo, Matteo-Maria, Frediani, Bruno, Tosi, Gian Marco, Cantarini, Luca, Fabiani, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589879/ https://www.ncbi.nlm.nih.gov/pubmed/34476773 http://dx.doi.org/10.1007/s40123-021-00393-8 |
Ejemplares similares
-
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021) -
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
por: Fabiani, Claudia, et al.
Publicado: (2020) -
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis
por: Della Casa, Francesca, et al.
Publicado: (2022) -
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience
por: Sota, Jurgen, et al.
Publicado: (2020) -
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis
por: Conticini, Edoardo, et al.
Publicado: (2020)